drugset / Trial / NCT02226991
Effects of Steady-state Efavirenz 600 mg QD (Sustiva®) on Tipranavir Concentration at Steady-state in Healthy Adult Volunteers
NaSingle-groupOpen-labelTreatment
Summary
Study to investigate the effects of steady-state Efavirenz (600 mg QD) on the steady-state pharmacokinetics of Tipranavir (500 mg BID) coadministered with Ritonavir (200 mg BID)
Timeline
- Start
- 2006-04
- Primary completion
- 2006-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | 600 mg | — |
| Subject | Tipranavir | Small molecule | 500 mg | — |
| Background | Ritonavir | Other / unclassified | 200 mg | — |
Indications
No indication recorded.